Examples of using Booster dose in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
approximately one year previously, consideration may be given to administering a booster dose.
Booster dose For continuous protection against cholera a single booster dose is recommended within 2 years for adults and children from 6 years of age, and after 6 months for children aged 2 to 6 years.
Prevenar(three doses at 2, 3.5, 6 months and a booster dose at approximately 12 months) and Meningitec(meningococcal C conjugate vaccine; two doses at 2 and 6 months and a booster dose at approximately 12 months)
A booster dose must be given.
The need for booster dose(s) has not been investigated.
A booster dose is recommended before the end of the second year of life.
pharmacist will inform you if a booster dose should be given.
The booster dose should preferably be given at least 6 months after the last primary dose. .
To complete a primary immunisation course or as a booster dose in subjects who have previously.
The need for, or timing of, a booster dose with ZOSTAVAX has not yet been determined.
Alternatively, subjects primed with Twinrix Adult may be administered a booster dose of either of the monovalent vaccines.
Alternatively, subjects primed with Twinrix Paediatric may be administered a booster dose of either of the monovalent vaccines.
Furthermore, 19,466 children and 116 preterm infants received a booster dose of Synflorix in the second year of life.
Following the booster dose, 96.6% of toddlers developed anti-HBs titres equal to or greater than 10 mIU/ ml.
Following the booster dose, 96.6% of toddlers developed anti-HBs titres equal to or greater than 10 mIU/ml.
The vaccine effectiveness was of 96.7% for the full primary series, and 98.5% for booster dose irrespective of priming.
In situations where a booster dose of both hepatitis A and hepatitis B are desired,
No increase in reactions was reported when a booster dose is administered 6 months-18 months later after the initial dosing series.
3285 received a booster dose in the second year of life.
The frequency of vaccine-related adverse experiences after the booster dose of ZOSTAVAX was generally similar to that seen with the first dose. .
